Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type
Clinical trial NCT02249403 · COMPLETED
Trial details
- NCT number
- NCT02249403
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-01-01
- Primary completion
- 2000-01-01
- Enrollment
- 362
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.